Documentación adicional
Coming of age: ten years of next-generation sequencing technologies.
The current state of Molecular Testing in the BRAF- Mutated Melanoma Landscape.
Mutation research- reviews in mutation research.
Context is everything: aneuploidy in cancer.
Implementing personalized cancer genomics in clinical trials.
MET- dependent solid tumours- molecular diagnosis and targeted therapy.
Assembling and validating bioinformatic pipelines for next- generation sequencing clinical assays.